Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [41] Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
    Stefanova, Dessislava I.
    Bose, Arpita
    Ullmann, Timothy M.
    Limberg, Jessica N.
    Finnerty, Brendan M.
    Zarnegar, Rasa
    Fahey, Thomas J.
    Beninato, Toni
    WORLD JOURNAL OF SURGERY, 2020, 44 (02) : 452 - 460
  • [42] Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study
    Nickel, Brooke
    Brito, Juan P.
    Moynihan, Ray
    Barratt, Alexandra
    Jordan, Susan
    McCaffery, Kirsten
    BMC CANCER, 2018, 18
  • [43] Current management of pediatric thyroid disease and differentiated thyroid cancer
    Tracy, Elisabeth T.
    Roman, Sanziana A.
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (01) : 37 - 42
  • [44] Patient Perspectives on the Extent of Surgery and Radioactive Iodine Treatment for Low-Risk Differentiated Thyroid Cancer
    Lubitz, Carrie C.
    Kiernan, Colleen M.
    Toumi, Asmae
    Zhan, Tiannan
    Roth, Mara Y.
    Sosa, Julie A.
    Tuttle, R. Michael
    Grubbs, Elizabeth G.
    ENDOCRINE PRACTICE, 2021, 27 (05) : 383 - 389
  • [45] Treatment for papillary thyroid microcarcinoma
    Shi, Lan
    Chen, Jun-hua
    Wang, Shun-tao
    Xiong, Yi-quan
    Huang, Tao
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (01): : 20 - 23
  • [46] Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review
    Ito, Yasuhiro
    Miyauchi, Akira
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2020, 15 (01) : 5 - 12
  • [47] Current controversies in the management of neck node metastasis in differentiated thyroid cancer
    Shaha, Ashok R.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
  • [48] Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid
    Ito, Yasuhiro
    Miyauchi, Akira
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3205 - 3215
  • [49] Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
    Wu, Xin
    Li, Binglu
    Zheng, Chaoji
    He, Xiaodong
    CANCER MEDICINE, 2023, 12 (06): : 7560 - 7566
  • [50] Management of incidental and non-incidental papillary thyroid microcarcinoma
    Elliott, M. S.
    Gao, K.
    Gupta, R.
    Chua, E. L.
    Gargya, A.
    Clark, J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2013, 127 : S17 - S23